These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 11228368
1. Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems. Morris-Downes MM, Phenix KV, Smyth J, Sheahan BJ, Lileqvist S, Mooney DA, Liljeström P, Todd D, Atkins GJ. Vaccine; 2001 Feb 28; 19(15-16):1978-88. PubMed ID: 11228368 [Abstract] [Full Text] [Related]
2. Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development. Phenix KV, Wark K, Luke CJ, Skinner MA, Smyth JA, Mawhinney KA, Todd D. Vaccine; 2001 Apr 30; 19(23-24):3116-23. PubMed ID: 11312006 [Abstract] [Full Text] [Related]
3. A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model. Morris-Downes MM, Sheahan BJ, Fleeton MN, Liljeström P, Reid HW, Atkins GJ. Vaccine; 2001 Jul 16; 19(28-29):3877-84. PubMed ID: 11427261 [Abstract] [Full Text] [Related]
7. Immune responses in mice vaccinated with a suicidal DNA vaccine expressing the hemagglutinin glycoprotein from the peste des petits ruminants virus. Wang Y, Liu G, Shi L, Li W, Li C, Chen Z, Jin H, Xu B, Li G. J Virol Methods; 2013 Nov 16; 193(2):525-30. PubMed ID: 23896018 [Abstract] [Full Text] [Related]
8. Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response. Colmenero P, Berglund P, Kambayashi T, Biberfeld P, Liljeström P, Jondal M. Gene Ther; 2001 Sep 16; 8(17):1307-14. PubMed ID: 11571567 [Abstract] [Full Text] [Related]
10. Manipulation of the Semliki Forest virus genome and its potential for vaccine construction. Atkins GJ, Sheahan BJ, Liljeström P. Mol Biotechnol; 1996 Feb 16; 5(1):33-8. PubMed ID: 8853014 [Abstract] [Full Text] [Related]
11. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus. Martinon F, Brochard P, Ripaux M, Delache B, Aurégan G, Vaslin B, Le Grand R. Vaccine; 2008 Jan 24; 26(4):532-45. PubMed ID: 18093703 [Abstract] [Full Text] [Related]
12. Semliki Forest virus vectors for gene therapy. Lundstrom K. Expert Opin Biol Ther; 2003 Aug 24; 3(5):771-7. PubMed ID: 12880377 [Abstract] [Full Text] [Related]
18. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines. Fernández IM, Harmsen M, Benaissa-Trouw BJ, Stuij I, Puyk W, Meloen RH, Snippe H, Kraaijeveld CA. Vaccine; 1998 Oct 24; 16(16):1531-6. PubMed ID: 9711800 [Abstract] [Full Text] [Related]
19. Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector. Murphy AM, Sheahan BJ, Atkins GJ. Int J Cancer; 2001 Nov 24; 94(4):572-8. PubMed ID: 11745446 [Abstract] [Full Text] [Related]